Rani Therapeutics Competitors and Similar CompaniesClear all

Rani Therapeutics's competitors and similar companies include Principia BioPharma, Oramed Pharmaceuticals and Arbutus Biopharma.

	Rani Therapeutics Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics.	Principia BioPharma Principia Biopharma is a biopharmaceutical company offering oral therapies to immunology and oncology patients.	Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies.	Arbutus Biopharma Arbutus Biopharma is a clinical-stage biopharmaceutical company that focuses on virology.
Founding Date	Founding Date 2012	Founding Date 2008	Founding Date 2006	Founding Date 2005
Type	Type Public	Type Subsidiary	Type Public	Type Public
Tags	Tags Technology bioengineering biotech clinical research pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech diabetes pharma	Tags Healthcare biotech drug development pharma
Locations	Locations San Jose, US HQ	Locations South San Francisco, US HQ	Locations New York, US HQ Jerusalem, IL	Locations Warminster, US HQ
Employees	Employees 71	Employees 18	Employees 1417% increase	Employees 1957% decrease
Valuation ($)	Valuation ($) 135.4 m	Valuation ($) N/A	Valuation ($) 94.2 m	Valuation ($) 762.7 m
Financial
Revenue (est.)	Revenue (est.) $1.6m (FY, 2025)	Revenue (est.) $35.2m (FY, 2019)	Revenue (est.) $2m (FY, 2025)	Revenue (est.) $14.1m (FY, 2025)
Net income	Net income ($41m) (FY, 2025)	Net income ($53.8m) (FY, 2019)	Net income $64m (FY, 2025)	Net income ($33.5m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 176.5m	Total funding raised $ 89.9m	Total funding raised $ 1m	Total funding raised N/A